Cas:129940-50-7 (2S)-2-[(Trityloxy)methyl]oxirane manufacturer & supplier

Chemical Name:(2S)-2-[(Trityloxy)methyl]oxirane

CAS.NO:129940-50-7

Synonyms:(S)-Glycidyl Trityl Ether;(2S)-2-[(Trityloxy)methyl]oxirane;(2S)-2-(trityloxymethyl)oxirane;(S)-Glycidyl Triphenylmethyl Ether;(S)-(−)-Glycidyl trityl ether;MFCD00273373;Oxirane, 2-[(triphenylmethoxy)methyl]-, (2S)-;(S)-2-(Triphenylmethoxymethyl)oxirane;(S)-(-)-Glycidyl trityl ether;(2S) 2 (TRITYLOXYMETHYL)OXIRANE

Molecular Formula:C₂₂H₂₀O₂

Molecular Weight:316.393

HS Code:2910900090

Physical and Chemical Properties:

Melting point:98-101ºC

Boiling point:438.8±40.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.603

PSA:21.76000

Exact Mass:316.146332

LogP:6.50

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:NONH for all modes of transpor

Packing Group:

Contact us for information like (S)-Glycidyl Trityl Ether chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S) 2 (TRITYLOXYMETHYL)OXIRANE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(S)-(−)-Glycidyl trityl ether Use and application,(S)-2-(Triphenylmethoxymethyl)oxirane technical grade,usp/ep/jp grade.

Related News: From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. (2S)-2-[(Trityloxy)methyl]oxirane manufacturer The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China��s public hospitals, where most Chinese people buy their drugs. (2S)-2-[(Trityloxy)methyl]oxirane supplier AXON is planning a follow-up trial that will include a better-defined group of Alzheimer’s patients suffering from both amyloid plaques and tau tangles, Novak said. (2S)-2-[(Trityloxy)methyl]oxirane vendor From a global perspective, China’s API companies have also performed well. According to the report of the American Transparent Medicine website, in 2016 the top ten pharmaceutical companies in the global API market, Chinese pharmaceutical companies accounted for 6 seats. (2S)-2-[(Trityloxy)methyl]oxirane factory Under the terms of the agreement, ICIG will purchase substantially all of the pharmaceutical intermediates business, excluding the drug delivery technologies portion of the business.